You will now be redirected to the GD3 website
Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Chemistry
- Asymmetric Synthesis
- High-Speed Synthesis and purification
- Metabolite Synthesis (Phase I and II)
- Molecular Probes (Fluorophores and Biotinylated Targets)
- Structure Identification and Characterization
- Stable Isotopically Labeled Compounds (2H, 13C, 15N, 34S)
- Specific Chemistry Expertise
- Natural Product Synthesis
- Instrumentation and Computing
Organic Synthesis
Making Molecules that Matter
Modern organic synthesis is the ever-evolving science of building complex molecules. Specific objectives for synthetic methods vary depending on the application. Cost, scale, ease of purification and target flexibility are often considerations. Scientists at GD3 have extensive experience working on diverse projects, each with their own synthetic challenges.
From rapidly optimizing chemical templates in drug discovery programs to asymmetric synthesis, heterocyclic compounds, natural products, amino acids, parallel synthesis and process development, we have the capabilities and experience to tackle the most complex chemistry challenges.
Learn more about